# FDA Inspection 1154304 - Peter Charles Klatsky MD Inc - October 07, 2021

Source: https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/ea71e175-7e01-4c70-85d3-0f5878dfa708
Source feed: FDA_Inspections

> FDA Inspection 1154304 for Peter Charles Klatsky MD Inc on October 07, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1154304
- Company Name: Peter Charles Klatsky MD Inc
- Inspection Date: 2021-10-07
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1224006 - 2023-11-06](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/48ded927-b0d9-41d8-a965-d2321c820669)
- [FDA Inspection 1224006 - 2023-11-06](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/40401af7-4017-4f49-8e27-771723c53e1c)
- [FDA Inspection 1154304 - 2021-10-07](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/afebf303-d339-4474-b652-fafd768bffc7)
- [FDA Inspection 1154304 - 2021-10-07](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/a8f3b043-44dc-4b74-951f-4c0ca4844a23)

Company: https://www.keypedia.com/companies/peter-charles-klatsky-md-inc/a5d02daa-1336-4f00-9b18-c3253fe8f36b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d